Literature DB >> 2969326

Specific, high affinity receptors for insulin-like growth factor II in the rat kidney glomerulus.

J F Haskell1, D J Pillion, E Meezan.   

Abstract

Rat renal glomeruli were isolated by a technique involving kidney perfusion with a solution containing magnetic iron oxide particles, followed by homogenization, sieving, and concentration over a strong magnet. Isolated glomeruli were treated with 1% Triton X-100 to solubilize plasma membrane components, while insoluble basement membrane components were removed by centrifugation. [125I]Insulin-like growth factor II (IGF-II) binding to this preparation was competitively inhibited by increasing amounts of unlabeled IGF-II, with 50% inhibition at an IGF-II concentration of 1 ng/ml. [125I]IGF-II was covalently cross-linked with disuccinimidyl suberate to its receptor in rat renal glomeruli and a specific high mol wt (255,000) band could be identified on autoradiograms of dodecyl sulfate-polyacrylamide gels. [125I]IGF-II binding and cross-linking to this band was inhibited by a polyclonal antibody against the type II IGF receptor. These results demonstrate for the first time that the isolated rat renal glomerulus contains a high affinity receptor for IGF-II.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2969326     DOI: 10.1210/endo-123-2-774

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  2 in total

1.  Beneficial effect of insulin-like growth factor-1 on hypoxemic renal dysfunction in the newborn rabbit.

Authors:  Anne Prévot; Monique Julita; David K Tung; Dolores Mosig
Journal:  Pediatr Nephrol       Date:  2009-01-24       Impact factor: 3.714

2.  Receptor-mediated endocytosis of α-galactosidase A in human podocytes in Fabry disease.

Authors:  Thaneas Prabakaran; Rikke Nielsen; Jakob V Larsen; Søren S Sørensen; Ulla Feldt-Rasmussen; Moin A Saleem; Claus M Petersen; Pierre J Verroust; Erik I Christensen
Journal:  PLoS One       Date:  2011-09-19       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.